Walnut Creek, CALIFORNIA4 Active Studies

Hereditary Angioedema Clinical Trials in Walnut Creek, CALIFORNIA

Find 4 actively recruiting hereditary angioedema clinical trials in Walnut Creek, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
2
Sponsors
476
Enrolling

Recruiting Hereditary Angioedema Studies in Walnut Creek

RecruitingWalnut Creek, CALIFORNIANCT06842823

A Study of Navenibart in Participants With Hereditary Angioedema

This is a Phase 3 multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of subcutaneous administration of navenibart in adult and adolescent parti...

145 participants
Astria Therapeutics, Inc.
View Study Details
RecruitingWalnut Creek, CALIFORNIANCT06679881

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

This is a Phase 3, multicenter, long-term, open-label study to evaluate the safety and efficacy of once-daily orally administered deucrictibant extended-release tablet for prophylaxis to prevent angio...

130 participants
Pharvaris Netherlands B.V.
View Study Details
RecruitingWalnut Creek, CALIFORNIANCT06343779

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, 2-period, 2-treatment cross-over study to evaluate the efficacy and safety of orally administered deucrictibant compared t...

120 participants
Pharvaris Netherlands B.V.
View Study Details
RecruitingWalnut Creek, CALIFORNIANCT06669754

Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of once-daily orally administered deucrictibant extended-release tablet compared ...

81 participants
Pharvaris Netherlands B.V.
View Study Details

About Hereditary Angioedema Clinical Trials in Walnut Creek

Hereditary angioedema (HAE) is a rare genetic condition causing recurrent episodes of severe swelling in various body parts. It is caused by deficiency or dysfunction of C1 inhibitor protein. Treatment includes on-demand therapy for attacks and prophylactic medications to prevent episodes.

There are currently 4 hereditary angioedema clinical trials recruiting participants in Walnut Creek, CALIFORNIA. These studies are seeking a combined 476 participants. Research is being sponsored by Astria Therapeutics, Inc., Pharvaris Netherlands B.V.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hereditary Angioedema Clinical Trials in Walnut Creek — FAQ

Are there hereditary angioedema clinical trials in Walnut Creek?

Yes, there are 4 hereditary angioedema clinical trials currently recruiting in Walnut Creek, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Walnut Creek?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Walnut Creek research site will contact you about next steps.

Are clinical trials in Walnut Creek free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Walnut Creek studies also compensate for your time and travel.

What hereditary angioedema treatments are being tested?

The 4 active trials in Walnut Creek are testing new therapies including novel drugs, biologics, and treatment approaches for hereditary angioedema.

Data updated March 2, 2026 from ClinicalTrials.gov